U.S. flag

An official website of the United States government

Filters

See more specimen types...
See more states

Other countries

Results: 1 to 20 of 28

Tests names and labsConditionsGenes, analytes, and microbesMethods

SmartMeds+ Pharmacogenomic Testing By Innovative GX Health

Innovative Genomics InnovativeGx Health
United States
167
  • T Targeted variant analysis

Psych HealthPGx Panel

RPRD Diagnostics, LLC
United States
4013
  • D Deletion/duplication analysis
  • T Targeted variant analysis

Whole Pharmacogenomics Scan

RPRD Diagnostics, LLC
United States
10769
  • D Deletion/duplication analysis
  • T Targeted variant analysis

RightMed Mental Health test

OneOme, LLC
United States
615
  • D Deletion/duplication analysis
  • T Targeted variant analysis

Genomind Pharmacogenetic Report

Genomind, Inc. Genomind, Inc
United States
1427
  • T Targeted variant analysis

GeneSight Psychotropic

Assurex Health, Inc.
United States
614
  • D Deletion/duplication analysis
  • T Targeted variant analysis

Tempus nP

Tempus Labs, Inc.
United States
413
  • T Targeted variant analysis

Psychotropic Pharmacogenomics Gene Panel

Mayo Clinic Laboratories Mayo Clinic
United States
122
  • T Targeted variant analysis

PGx-NP (Neuro-Psychiatry)

SPMED CO., LTD Step forward Personalized Medicine
South Korea
5126
  • T Targeted variant analysis

Anorexia nervosa, susceptibility to, 606788 (HTR2A gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Major depressive disorder, response to citalopram therapy in, 608516 (HTR2A gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Schizophrenia, susceptibility to, 181500, Autosomal dominant (HTR2A gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Seasonal affective disorder, susceptibility to, 608516 (HTR2A gene) (Sequence Analysis-All Coding Exons) (Prenatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Seasonal affective disorder, susceptibility to, 608516 (HTR2A gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Obsessive-compulsive disorder, susceptibility to, 164230, Autosomal dominant; OCD (HTR2A gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Alcohol dependence, susceptibility to, 103780, Multifactorial (HTR2A gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

NeuroIDgenetix

AltheaDx/Castle Biosciences
United States
211
  • D Deletion/duplication analysis
  • T Targeted variant analysis

qGenEx Intellectual disability

Quantitative Genomic Medicine Laboratories, SL
Spain
31969
  • S Mutation scanning of the entire coding region
  • C Sequence analysis of the entire coding region

Pharmacogenetics Panel: Psychotropics

ARUP Laboratories, Molecular Genetics and Genomics ARUP Laboratories
United States
814
  • E Sequence analysis of select exons

Autism Spectrum Gene Panel

Duzen Laboratories Duzen BBAGUAS
Turkey
1160
  • C Sequence analysis of the entire coding region

Results: 1 to 20 of 28

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.